Zhou T - Search Results

1

The essential role of forkhead box P4 (FOXP4) in thyroid cancer: a study related to The Cancer Genome Atlas and experimental data.

Zhou T, Zhao DW, Ma N, Zhu XY, Chen XH, Luo X, Chen S, Gao QJ. Zhou T, et al. Endocr Connect. 2023 Mar 15;12(4):e220390. doi: 10.1530/EC-22-0390. Print 2023 Apr 1. Endocr Connect. 2023. PMID: 36752821 Free PMC article.

2

Progress in application of long non-coding RNA in the diagnosis and treatment of thyroid cancer.

Zhou T, Wang LK, Huang YX, Zhao DW. Zhou T, et al. Asian J Surg. 2022 Oct;45(10):1971-1972. doi: 10.1016/j.asjsur.2022.04.039. Epub 2022 Apr 28. Asian J Surg. 2022. PMID: 35491371 Free article. No abstract available.

3

FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.

Luo X, Gao Q, Zhou T, Tang R, Zhao Y, Zhang Q, Wang N, Ye H, Chen X, Chen S, Tang W, Zhao D. Luo X, et al. Among authors: zhou t. Front Oncol. 2022 Jun 2;12:900836. doi: 10.3389/fonc.2022.900836. eCollection 2022. Front Oncol. 2022. PMID: 35720005 Free PMC article.

4

Transcription factor FOXP4 inversely governs tumor suppressor genes and contributes to thyroid cancer progression.

Zhou T, Ma N, Zhang YL, Chen XH, Luo X, Zhang M, Gao QJ, Zhao DW. Zhou T, et al. Heliyon. 2024 Jan 7;10(2):e23875. doi: 10.1016/j.heliyon.2023.e23875. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38293397 Free PMC article.

5

A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma.

Ma N, Zhou T, Li C, Luo X, Chen S, Zhu XY, Chen XH, Liu H, Tian HY, Gao QJ, Zhao DW. Ma N, et al. Among authors: zhou t. Heliyon. 2024 Jan 19;10(3):e24455. doi: 10.1016/j.heliyon.2024.e24455. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38314298 Free PMC article.

6

ACTN1 promotes cell invasion, migration, and EMT in thyroid cancer and is associated with immune infiltration.

Chen S, Luo X, Wang W, Chen XH, Ma N, Zhu XY, Zhou T, Gao QJ, Zhao DW. Chen S, et al. Among authors: zhou t. Sci Rep. 2024 Dec 30;14(1):32060. doi: 10.1038/s41598-024-83719-3. Sci Rep. 2024. PMID: 39738470 Free PMC article.

7

Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.

Bao G, Huang J, Pan W, Li X, Zhou T. Bao G, et al. Among authors: zhou t. Cancer Med. 2020 Jan;9(1):278-289. doi: 10.1002/cam4.2675. Epub 2019 Nov 8. Cancer Med. 2020. PMID: 31701672 Free PMC article.

8

GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7.

Zhou T, Yu L, Huang J, Zhao X, Li Y, Hu Y, Lei Y. Zhou T, et al. Aging (Albany NY). 2019 May 31;11(10):3298-3314. doi: 10.18632/aging.101983. Aging (Albany NY). 2019. PMID: 31147529 Free PMC article.

9

PLU1 Promotes the Proliferation and Migration of Glioma Cells and Regulates Metabolism.

Dong W, Wang L, Pan Y, Tu Q, He T, Zhou T, Yuan J, Tong M. Dong W, et al. Among authors: zhou t. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231175768. doi: 10.1177/15330338231175768. Technol Cancer Res Treat. 2023. PMID: 37254514 Free PMC article.

10

MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1.

Tang Y, Zhu Q, Yang L, Meng Y, Zhang G, Zhou T, Wang C, Song X, Su YX, Ye J. Tang Y, et al. Among authors: zhou t. Cell Signal. 2023 Sep;109:110748. doi: 10.1016/j.cellsig.2023.110748. Epub 2023 Jun 7. Cell Signal. 2023. PMID: 37290676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,249 results

Search Page

Filters